Contact – Daniel.Kimbell@lozaip.com  | (818) 510-4834

Dan is an AV^®-rated, registered patent attorney with over three decades of experience in patent and trademark prosecution, as well as IP licensing. Over the course of his career, he has prosecuted and secured more than 1,000 patents and thousands of trademarks for clients spanning numerous technical and business fields. Although Dan’s practice is grounded in rigorous patent and trademark work, he also delivers high-level counseling to organizations seeking to leverage their IP for strategic growth. His comprehensive approach enables companies—from startups to well-established corporations—to clarify their competitive positioning, expand revenue streams, and defend their market presence. Dan’s guiding principle is to align each legal decision with practical business goals, ensuring that every patent secured or trademark registered serves a larger vision of long-term value and marketplace differentiation.

because he brings to his legal work significant, firsthand entrepreneurial experience. Having co-founded four startup companies, Dan has an insider’s understanding of the complexities and time-sensitive demands that early-stage ventures face. Dan co-founded Emmaus Life Sciences, Inc. www.emmausmedical.com) and served as its Chief Operating Officer for a decade. During his tenure, Emmaus achieved multiple milestones—running pivotal clinical trials for sickle cell disease treatments, licensing third-party pharmaceuticals, and building foundational business processes that paved the way for growth, and ultimately FDA approval and commercial launch of its commercial product Endari® (L-glutamine oral powder) to treat sickle cell anemia and sickle β0-thalassemia.

Dan’s breadth of experience—spanning patent drafting, trademark strategy, licensing, and executive-level operations—uniquely enables Dan to deliver actionable IP insight and actions.